Full history for every metric is available with a Kvantra account

Stock profile

Carmat S.A. (ALCAR.PA)

Country: FranceSector: HealthcareIndustry: Medical - DevicesExchange: PAR

Delisted · last close 20 Oct 2025

Current price
0.10 EUR0.00%
Last close 20 Oct 2025
Benchmarks

Key financial summary

Financials in EUR
201920202021202220232024TTM
Total revenue€m0020377
Operating profit€m-49-67
Net profit€m-43-37-62-54-54-51-51
EPS reported€-2.26-2.26
Operating cashflow per share€-1.90-1.90
Capex per share€0.070.07
FCF per share€-1.97-1.97
Free cash flow€m-45-45
Net debt€m5353
Book value equity€m-51-51
Book value per share€-2.24-2.24
Number of sharesm22.7822.78
DPS (TTM paid)€0.000.00

Financial summary

Financials in EUR
201920202021202220232024TTM
Value
P/E TTMx--
P/B LTMx-0.49-0.12
P/S LTMx3.550.91
P/FCF LTMx-0.55-0.14
EV/EBITDA LTMx-1.56-0.89
EV/Sales LTMx11.138.48
Earnings Yield LTM%-206.98%-2278.9%
FCF Yield%-180.50%-704.64%
Quality
ROE%100.53%106.81%
ROIC%-185.69%-185.69%
Operating margin%-702.86%-702.86%
Gross margin%-336.56%-336.56%
FCF/Sales%-640.33%-640.33%
Growth and momentum
EPS Growth YoY%--
Sales Growth YoY%+145.79%+145.79%
Net Income Growth YoY%--
FCF Growth%--
Operating Profit Growth%--
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%0.00%0.00%
Payout Ratio%0.00%0.00%
FCF/Debtx-0.78-0.78
Net Debt/EBITDAx-1.07-1.07
EBIT/Net interestx-15.38-15.38
Net debt/market cap%213.82%834.71%
Net debt/Equityx-1.04-1.04
Gross debt/equityx-1.13-1.13

Company overview

Carmat SA specializes in engineering and creating a full artificial heart, specifically designed for individuals worldwide who are afflicted with severe, late-stage biventricular heart failure. The company commenced operations in 2008 and is based in Vélizy-Villacoublay, France.

WebsiteN/A
IndustryMedical - Devices
CountryFrance
Trades inEUR

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 20 Oct 2025

Carmat S.A. (ALCAR.PA)

ALCAR.PA · PAR · Healthcare
0.10 EUR0.00%
Benchmarks
Financialsin EUR
20232024TTM
About

Carmat SA specializes in engineering and creating a full artificial heart, specifically designed for individuals worldwide who are afflicted with severe, late-stage biventricular heart failure. The company commenced operations in 2008 and is based in Vélizy-Villacoublay, France.

IndustryMedical - Devices
CountryFrance
Trades inEUR

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free